Cabazitaxel EVER Pharma
10 mg/ml concentrate for, infusion solution, solution for injection.
6 ml vial containing concentrate for infusion solution, solution contains cabazitaxel monohydrate or anhydrous cabazitaxel equivalent to 60 mg cabazitaxel.
Used in combination with prednisone or prednisolone is indicated for the treatment of adult patients with metastatic castration-resistant prostate cancer.
No special storage instructions before preparation. Do not freeze.
One package contains a vial containing concentrate for infusion solution, solution.
Package size: 1 x 6 ml (60 mg)
Package size: 1x5ml (50mg)
Vnr: 192032 Cabazitaxel EVER Pharma 60 mg
Vnr: 483336 Cabazitaxel EVER Pharma 50 mg
For more information:
The page was last updated on 21/09/2020
Note that the appearance of the packaging may differ depending on the country.